Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-10T14:19:40.445Z Has data issue: false hasContentIssue false

Self-Immunization with Live Attenuated Influenza Vaccine in a Mass Vaccination Clinic

Published online by Cambridge University Press:  03 April 2013

Matt Zahn*
Affiliation:
Division of Pediatric Infectious Disease, University of Louisville School of Medicine, USA Louisville Metro Department of Public Health and Wellness, USA
Priscilla Pursiful
Affiliation:
Louisville Metro Department of Public Health and Wellness, USA
Ruth Carrico
Affiliation:
University of Louisville School of Public Health and Information Sciences, USA
Charles Woods
Affiliation:
Division of Pediatric Infectious Disease, University of Louisville School of Medicine, USA
Adewale Troutman
Affiliation:
Louisville Metro Department of Public Health and Wellness, USA University of Louisville School of Public Health and Information Sciences, USA
*
Address correspondence and reprint requests to Matt Zahn, MD, 1719 W 17th St, Santa Ana, CA 92706. e-mail mzahn@ochca.com

Abstract

Objective

An influenza pandemic may demand that a large number of influenza immunizations be rapidly given with limited resources. This study tested the utility and practicality of self-immunization with live attenuated influenza intranasal vaccine in a mass vaccination event.

Methods

The self-immunization clinic model was evaluated in a three-tiered fashion using student, first responder, and open community events.

Results

A single nurse was easily able to direct 89 people through the process of self-administration of the vaccine in a three-hour first-responder event and 122 people in a three-hour open community event. 96% of participants believed that they had performed the self-administration correctly, and the same percentage reported that they would like to receive influenza immunization by self-vaccination in the future.

Conclusions

The self-immunization clinic is a practical and potentially useful model in an influenza pandemic setting.

Type
Commentary
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. FluMist [package insert]. Gaithersburg, MD: MedImune, LLC; 2012.Google Scholar
2.Nichol, K, Mendelman, P, Mallon, K, etal. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282(2):137-144.CrossRefGoogle ScholarPubMed
4.Ambrose, C, Wu, X. Effectiveness of Self-Administration of Intranasal Live Attenuated Influenza Vaccine in Adults. Poster presented at: 2012 Infectious Disease Society of America Conference; October 20, 2012; San Diego, California.Google Scholar